These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18802976)

  • 1. Labeling changes for Reyataz.
    AIDS Patient Care STDS; 2008 Sep; 22(9):761. PubMed ID: 18802976
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA notifications. Reyataz is approved for HIV treatment.
    AIDS Alert; 2003 Sep; 18(9):119-20. PubMed ID: 14686309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atazanavir gets FDA Advisory Committee's thumbs-up.
    IAPAC Mon; 2003 Jun; 9(6):120. PubMed ID: 12951939
    [No Abstract]   [Full Text] [Related]  

  • 4. Warning: do not combine Reyataz and Prilosec.
    AIDS Treat News; 2004; (407-408):5-6. PubMed ID: 15717382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMS issues PK notice regarding ATV + TDF.
    IAPAC Mon; 2003 Sep; 9(9):203. PubMed ID: 14672069
    [No Abstract]   [Full Text] [Related]  

  • 6. New protease inhibitor atazanavir (Reyataz) approved.
    AIDS Treat News; 2003 Jun; (392):3. PubMed ID: 12913956
    [No Abstract]   [Full Text] [Related]  

  • 7. Atazanavir (Reyataz).
    Proj Inf Perspect; 2003 Oct; (36):7-10. PubMed ID: 14696568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atazanavir background documents available.
    AIDS Treat News; 2003 May; (391):3. PubMed ID: 12866495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICAAC update. Three new drugs in development, plus Isentress with Reyataz.
    Vázquez E
    Posit Aware; 2010; 21(1):39-41. PubMed ID: 20524421
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA notifications. Updates made to Reyataz package insert.
    AIDS Alert; 2008 Oct; 23(10):116-7. PubMed ID: 18935687
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA notifications. Revised atazanavir package insert.
    AIDS Alert; 2008 Mar; 23(3):35-6. PubMed ID: 18661642
    [No Abstract]   [Full Text] [Related]  

  • 12. CASTLE data show no gender differences.
    AIDS Patient Care STDS; 2008 Sep; 22(9):762. PubMed ID: 18802980
    [No Abstract]   [Full Text] [Related]  

  • 13. CASTLE study showed similar efficacy.
    AIDS Patient Care STDS; 2008 Mar; 22(3):253. PubMed ID: 18348342
    [No Abstract]   [Full Text] [Related]  

  • 14. Three new drugs approved by FDA.
    Hoyt G
    Surviv News (Atlanta Ga); 2003; ():13, 20. PubMed ID: 14696579
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA notifications. Alternative dosing regimen for atazanavir is approved.
    AIDS Alert; 2008 Nov; 23(11):129-30. PubMed ID: 19048649
    [No Abstract]   [Full Text] [Related]  

  • 16. New atazanavir capsule approved.
    AIDS Patient Care STDS; 2006 Nov; 20(11):813. PubMed ID: 17134355
    [No Abstract]   [Full Text] [Related]  

  • 17. New pediatric dosing recommendations for atazanavir.
    AIDS Patient Care STDS; 2008 Apr; 22(4):347. PubMed ID: 18434948
    [No Abstract]   [Full Text] [Related]  

  • 18. 96-week CASTLE data show similar efficacy results.
    AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043840
    [No Abstract]   [Full Text] [Related]  

  • 19. Atazanavir: new indication. First-line treatment: fewer gastrointestinal disorders but more cases of jaundice and a risk of torsades de pointes.
    Prescrire Int; 2009 Jun; 18(101):104. PubMed ID: 19637415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New pediatric dosing information for Kaletra.
    AIDS Patient Care STDS; 2008 Jul; 22(7):604. PubMed ID: 18661592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.